Polyrizon anticipates completing the brand development process in alignment with its ongoing clinical and regulatory milestones.

Confirms Receipt of Two Director Nominees from Daniel J. ManglessStockholders Are Not Required to Take Action at This TimeCELEBRATION, Fla., ...

Whether investors can keep climbing this proverbial “wall of worry” may come down to the new U.S. administration’s policy agenda as it ultimately plays out over the next four years. While market ...